Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 30,000 shares at $106.35 ($3.2M) on 2024-11-01, disclosed to the SEC on 2024-11-04.
Scheduled sale ($3.2M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.35 | 9,955 | $1.1M | 33.0% |
| 2 | $106.35 | 9,955 | $1.1M | 33.0% |
| 3 | $107.34 | 3,312 | $356K | 11.1% |
| 4 | $107.34 | 3,312 | $356K | 11.1% |
| 5 | $108.50 | 1,733 | $188K | 5.9% |
| 6 | $108.50 | 1,733 |
| $188K |
| 5.9% |
| Total | $106.82 avg | 30,000 | $3.2M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |